Brinckerhoff Quoted on Patent Trolling in Biopharma
24 July 2013
Genetic Engineering and Biotechnology
Washington, D.C. Partner Courtenay Brinckerhoff was quoted in an article published in Genetic Engineering and Biotechnology News on July 24, 2013 titled “New Gene Patent Suit Sparks Talk of Trolls.” The article discusses a lawsuit issued by Myriad Genetics and whether or not it means patent trolling has come to biopharma. Ms. Brinckerhoff was quoted saying, “Before biotech companies decide to go into the market, they might be more cognizant or concerned about whether they have time to operate, because they’re going to invest a lot of time and money to get there.”
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."